News

ALLG has featured in The Limbic with our Scientific Advisory Committee Chair, Prof Judith Trotman, interviewed about our five decades of impact.

It's our pleasure to share with you the third Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

Sir Sam Neill, New Zealand (NZ) actor and blood cancer survivor supports the ALLG’s concerns of proposed NZ bill affecting clinical trials.

ALLG has featured in the Herald Sun and The Advertiser newspapers with "World first cancer trial" about a novel way to identify and treat patients with acute myeloid leukaemia (AML) before they [...]

Prof Hang Quach, Chair of ALLG's Myeloma Scientific Working Party talks about clinical trials in myeloma for better treatments…better lives.

Latest ‘State of the Nation: Blood Cancer in Australia’ report highlights progress and the actions still required to improve outcomes for patients.

March is International Myeloma Awareness Month; a chance to highlight this relatively rare blood cancer. The ALLG’s Myeloma Scientific Working Party trials new promising drugs to improve [...]

Rare cancers make up 25% of cancers in total, yet 40% of deaths. This matters because many blood cancers are rare. In Australia a rare cancer means they affect fewer than 6 diagnoses per 100, 000 [...]

Congratulations to ALLG Consumer Representative, Mr John Stubbs AM, who has been appointed a Member of the Order of Australia for ‘significant service to community health, particularly to people [...]

1 January 2023 marks the start of ALLG’s 50th Anniversary year! Since 1973, the ALLG has been conducting clinical trials focused on delivering new treatments and supporting better lives for [...]

An Australian Teletrial Program (ATP) is working to improve access to clinical trials for people living in rural and regional parts of the country. Vesselin Petkov from Cairns [pictured with his [...]

It's our pleasure to share with you the second Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

ALLG Member, Dr Ashley Ng, a WEHI Clinical Translational Research Fellow, has been awarded the prestigious Metcalf Prize for Stem Cell Research, for "Controlling rogue blood stem cells".

It's our pleasure to share with you the first ever Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

The ALLG has opened the first hospital site in Australia for a clinical trial that is a world first in acute myeloid leukaemia (AML) trials. The AMLM26 INTERCEPT study aims to radically change [...]

Her Majesty the Queen will be remembered for her devotion and commitment to the Commonwealth for many years to come. We pay tribute to the Queen’s 70 years of service. The Queen’s dedication to [...]

The ALLG trial BM12 CAST has been accepted for publication as an abstract at EHA. Congratulations to the Chief Investigators A/Prof David Curtis and Dr Sushrut Patil, and the trial team.

We are all extremely saddened to announce that our respected colleague and friend Associate Professor James D'Rozario MBBS, FRACP, FRCPA, Senior Staff Specialist and Clinical Director, Department [...]

Clinical trials generate the evidence needed to help close the care gap and improve global practices in cancer care. That’s what we do everyday at the Australasian Leukaemia and Lymphoma Group [...]

A preeminent expert in blood cancer, Professor Mark Hertzberg who has dedicated his life and career to advancing the medicine and science of leukaemia, lymphoma and other blood disorders in [...]

ALLG and HSANZ welcomes the Report tabled in Parliament 25/11/21 on ‘The New Frontier – Delivering better health for all Australians: Inquiry into approval processes for new drugs and novel [...]

Through partnerships and collaborations that we are able to create better treatments and better lives for blood cancer patients.

The Consumer Representative Panel is an invaluable source of information to members of the ALLG

Coming up to the end of the year, we would like to thank Natalia Racomelara and her family for their wonderful support.

The NBCR and Biobank was established by the ALLG in 2012.

Wow, what a year it’s been!

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.